6 -amidinopenicillanic acids--a new group of antibiotics.
about
Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitroMecillinam: a new antibiotic for enteric feverMecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitisThe Escherichia coli lov gene product connects peptidoglycan synthesis, ribosomes and growth rate.Mechanism of action and development of resistance to a new amidino penicillin.Penicillin binding protein 2 is dispensable in Escherichia coli when ppGpp synthesis is inducedSynergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.Transition state structures of a dipeptide related to the mode of action of beta-lactam antibiotics.Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coliDistinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12.Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency.Effects of mecillinam and cefoxitin on growth, macromolecular synthesis, and penicillin-binding proteins in a variety of streptococciPharmacokinetics of amdinocillin in healthy adultsThermoinducible filamentation in Escherichia coli due to an altered RNA polymerase beta subunit is suppressed by high levels of ppGppPenicillin-binding protein 2 inactivation in Escherichia coli results in cell division inhibition, which is relieved by FtsZ overexpression.Penicillin-binding protein 2 is essential in wild-type Escherichia coli but not in lov or cya mutantsPurification of penicillin-binding protein 2 of Escherichia coli.Effects of furazlocillin, a beta-lactam antibiotic which binds selectively to penicillin-binding protein 3, on Escherichia coli mutants deficient in other penicillin-binding proteins.Mapping of the mecillinam-resistant, round morphological mutants of Escherichia coli.Triggering of autolytic cell wall degradation in Escherichia coli by beta-lactam antibiotics.Mecillinam resistance in Escherichia coli is conferred by loss of a second activity of the AroK protein.Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acidGenome signature-based dissection of human gut metagenomes to extract subliminal viral sequences.Peptidoglycan synthesis in cocci and rods of a pH-dependent, morphologically conditional mutant of Klebsiella pneumoniae.The future of new oral antibiotics including the quinolones.Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillin.Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes.Identification of two new cell division genes that affect a high-molecular-weight penicillin-binding protein in Caulobacter crescentusHigh and selective resistance to mecillinam in adenylate cyclase-deficient or cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli.Penicillin-binding proteins in Proteus species.In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.Genetic and physiological analysis of an envB spherelike mutant of Escherichia coli K-12 and characterization of its transductants.Attachment of lipoprotein to murein (peptidoglycan) of Escherichia coli in the presence and absence of penicillin FL 1060.Comparison of the binding properties of two 6 beta-amidinopenicillanic acid derivatives that differ in their physiological effects on Escherichia coli.Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.Pharmacokinetics of pivmecillinam.Growth properties of mecillinam-resistant bacterial variants in urine.
P2860
Q24562128-912B2ABE-233A-4909-A1EB-B851E06EC2B1Q24673457-0958EE89-08B5-4449-B851-587B2D07B007Q30450457-2B79C6B2-EA84-46D6-9057-FAAF33096A73Q33558573-EEB55142-73F3-448C-A4E4-6DA495670288Q33792906-799E7575-196A-477B-9157-55BFEE4207B3Q33937646-2FFEA2C0-558C-4E3A-93A2-48D644DE419FQ34974053-8DAA7B0E-3F38-439B-BD99-8C8F55D5CED7Q34974999-7F48AFE7-E77D-4FFE-8E7D-6CCA6ED699F5Q35047545-E5C4D288-DF85-48B9-AF01-A34283478A55Q35076962-B612B3F8-AB68-4FA3-859C-686D15647954Q35085145-6573C498-D51A-4FB6-9FDF-F8F629782756Q35571325-4D0B227F-43BF-4B11-90E2-C3E850F2E825Q35742503-201ACECB-4E5E-4E93-828B-A3F89AA7F02CQ35744844-8BD9ECD0-B6AB-4626-B371-608772791EBAQ36105271-C4A163FB-A1DA-493E-B1E3-E5E07ED32E2AQ36123165-9EBFC50E-1377-4A7C-969E-532F9C506398Q36178171-AB1EB671-C091-4055-86DD-406F41803970Q36323333-B91A841B-EC0B-481A-B948-C80DA257BC6CQ36323874-AE9E09B8-3BF4-4619-ABE9-10154887CDD9Q36417251-5CD5E464-2FA5-4678-AA57-9F359022DCC0Q36486922-85D94E84-9C57-4EA8-AD0A-3170342A9F8FQ36574585-EC189309-2D2D-422C-83B3-F581C3A86563Q36763987-7D2CDC4B-C4F1-4216-AB90-98D09F065D21Q37186442-EB5EA524-C458-4465-9060-615BC6173C90Q39239141-564B8680-8F5B-4203-91C7-BF79B3787F89Q39625405-149CD040-BDA8-4EA4-AF84-10B312E36DF8Q39828499-64576296-81EC-422B-9F68-B7FE84DFF7EFQ39832604-8ACD2145-BE90-415B-85D7-169740CF167FQ39856429-91345FFF-2542-452C-9A3A-C5C91FE0F631Q39947648-6EE88DAD-FEBE-4613-94BF-DEA9DE95EB38Q39953222-CAB0F656-8183-4638-9723-EBBA5B4D684CQ39978543-19212E15-8DBF-4722-B80C-6DA778EB6CA3Q39978889-1BE4FD92-43D3-42F0-A6EC-B21C91A06B01Q39988366-6A057DD8-454B-488C-8879-2FC6994B25C1Q40035529-CF8D9E5E-38EB-4D46-BF45-2CA6C70538B2Q40035923-C90D0A60-7534-4CE3-AEB9-9A8BC102B433Q40046026-D791A1F4-39ED-4646-AE22-D64B3AF7CB81Q40074209-C1D70FC4-83C3-430E-B605-572162081020Q40097046-F20280A6-08DA-43C6-A91B-DB34C519CFA7Q40109921-F244949B-A84A-4799-9ED0-71DA558439AC
P2860
6 -amidinopenicillanic acids--a new group of antibiotics.
description
1972 nî lūn-bûn
@nan
1972 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
6 -amidinopenicillanic acids--a new group of antibiotics.
@ast
6 -amidinopenicillanic acids--a new group of antibiotics.
@en
6 -amidinopenicillanic acids--a new group of antibiotics.
@nl
type
label
6 -amidinopenicillanic acids--a new group of antibiotics.
@ast
6 -amidinopenicillanic acids--a new group of antibiotics.
@en
6 -amidinopenicillanic acids--a new group of antibiotics.
@nl
prefLabel
6 -amidinopenicillanic acids--a new group of antibiotics.
@ast
6 -amidinopenicillanic acids--a new group of antibiotics.
@en
6 -amidinopenicillanic acids--a new group of antibiotics.
@nl
P1433
P1476
6 -amidinopenicillanic acids--a new group of antibiotics.
@en
P2093
P304
P577
1972-04-01T00:00:00Z